萨科佩尼亚的诊断标准及其与老年人功能表现的关联
Mohammad Nikkhoo1,2, Po-Hsiang Tsui3, Carl P C Chen4
1School of Physical Therapy and Graduate Institute of Rehabilitation Science, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Journal of aging and physical activity
|September 12, 2025
概括
麻症的患病率及其对身体功能的影响在老年人中因使用的诊断标准而有很大差异. 在临床实践中,选择适当的标准对于准确的查和有效的干预至关重要.
科学领域:
- 老年学是一门学科.
- 肌肉骨健康 肌肉骨健康
- 衰老研究研究 衰老研究
背景情况:
- 随着年龄的增长,肌肉质量和力量的丧失导致的萨尔科佩尼亚严重影响了老年人的运动能力和功能能力.
- 目前存在的麻症诊断标准,包括欧洲和亚洲工作组的诊断标准,可能会产生不同的患病率,并影响功能结果.
研究的目的:
- 用四个不同的诊断标准,比较了老年人肉类的患病率及其与身体健康结果的关联.
- 评估功能评估测试在识别不同标准的萨尔科佩尼亚的有效性.
主要方法:
- 一项涉及377名台湾族裔社区老年人的横截面研究.
- 参与者接受了七项功能评估测试,并使用欧洲老年肉病工作组 (EWGSOP) -2,EWGSOP-1,亚洲肉病工作组 (AWGS) -2,和AWGS-1的标准诊断出肉病.
- 统计分析包括描述性统计,相关性,后勤回归和接收器运行特征 (ROC) 分析,以评估肉症标准和功能性能之间的关系.
主要成果:
- 根据标准,肉病的患病率有很大差异:EWGSOP-2 (3.7%),AWGS-2 (11.1%),AWGS-1 (6.6%) 和EWGSOP-1 (39.0%).
- 在功能测试和肉症之间观察到显著的相关性,被诊断为肉症的个体表现出较差的功能表现.
- 经过ROC分析,证明了功能测试在区分肉症方面的有用性,曲线下面积的值在不同标准中从0.686到0.787不等.
结论:
- 诊断标准的选择显著影响了老年人中的石病的患病率及其功能影响.
- 功能性评估测试在识别肉类症方面是有效的,但它们的辨别力根据所应用的标准而有所不同.
- 为准确的查,功能性评估和在临床环境中开发有针对性的干预措施,选择适合环境的麻症标准至关重要.
更多相关视频
12:59Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
Published on: July 5, 2017
13.1K
13:35Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
Published on: March 21, 2021
11.6K
相关概念视频
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
238
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
238
Pharmacodynamics in Geriatric Patients: Effects of Age
190
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
190
